156 related articles for article (PubMed ID: 14611672)
1. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand.
Niho N; Takahashi M; Shoji Y; Takeuchi Y; Matsubara S; Sugimura T; Wakabayashi K
Cancer Sci; 2003 Nov; 94(11):960-4. PubMed ID: 14611672
[TBL] [Abstract][Full Text] [Related]
2. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
[TBL] [Abstract][Full Text] [Related]
3. Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Mutoh M; Niho N; Wakabayashi K
Biol Chem; 2006 Apr; 387(4):381-5. PubMed ID: 16606335
[TBL] [Abstract][Full Text] [Related]
4. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Niho N; Mutoh M; Takahashi M; Tsutsumi K; Sugimura T; Wakabayashi K
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2970-4. PubMed ID: 15710887
[TBL] [Abstract][Full Text] [Related]
5. Improvement of hyperlipidemia by indomethacin in Min mice.
Niho N; Mutoh M; Komiya M; Ohta T; Sugimura T; Wakabayashi K
Int J Cancer; 2007 Oct; 121(8):1665-9. PubMed ID: 17546600
[TBL] [Abstract][Full Text] [Related]
6. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma.
Kageyama H; Hirano T; Okada K; Ebara T; Kageyama A; Murakami T; Shioda S; Adachi M
Biochem Biophys Res Commun; 2003 May; 305(1):22-7. PubMed ID: 12732191
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats.
Naito Y; Takagi T; Uchiyama K; Handa O; Tomatsuri N; Imamoto E; Kokura S; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):294-9. PubMed ID: 12688513
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
Ito H; Nakano A; Kinoshita M; Matsumori A
Lab Invest; 2003 Dec; 83(12):1715-21. PubMed ID: 14691289
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
Bavirti S; Ghanaat F; Tayek JA
Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
[TBL] [Abstract][Full Text] [Related]
12. PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages.
Iida KT; Kawakami Y; Suzuki H; Sone H; Shimano H; Toyoshima H; Okuda Y; Yamada N
FEBS Lett; 2002 Jun; 520(1-3):177-81. PubMed ID: 12044893
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro.
Duvanel CB; Honegger P; Pershadsingh H; Feinstein D; Matthieu JM
J Neurosci Res; 2003 Jan; 71(2):246-55. PubMed ID: 12503087
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
15. Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.
Foreman JE; Sorg JM; McGinnis KS; Rigas B; Williams JL; Clapper ML; Gonzalez FJ; Peters JM
Mol Carcinog; 2009 Oct; 48(10):942-52. PubMed ID: 19415698
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
Gupta RA; Wang D; Katkuri S; Wang H; Dey SK; DuBois RN
Nat Med; 2004 Mar; 10(3):245-7. PubMed ID: 14758356
[TBL] [Abstract][Full Text] [Related]
17. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
18. Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists.
Hase T; Yoshimura R; Mitsuhashi M; Segawa Y; Kawahito Y; Wada S; Nakatani T; Sano H
Urology; 2002 Sep; 60(3):542-7. PubMed ID: 12350514
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone.
Nakaya H; Summers BD; Nicholson AC; Gotto AM; Hajjar DP; Han J
Am J Pathol; 2009 Jun; 174(6):2007-14. PubMed ID: 19435790
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
